More about

Statin Therapy

News
January 08, 2020
4 min read
Save

HIV infection confers elevated risk for ASCVD, CV events

HIV infection confers elevated risk for ASCVD, CV events

Adults in the U.S. with HIV are still at an elevated risk for atherosclerotic CVD compared with individuals without HIV, regardless of changes in antiretroviral therapies and increased statin use.

News
January 04, 2020
2 min read
Save

Top prevention news of 2019: Women’s heart health, omega-3 updates and more

Top prevention news of 2019: Women’s heart health, omega-3 updates and more

Healio and Cardiology Today have compiled a list of the most-popular news on heart disease prevention published in 2019.

News
December 29, 2019
2 min read
Save

Top endocrinology news reports 2019: anti-aging, alternate-day fasting, insulin patch

Top endocrinology news reports 2019: anti-aging, alternate-day fasting, insulin patch

In 2019, Healio readers were interested in fertility preservation for men on testosterone therapy, the wonders of metformin, possible associations between statins and diabetes, a new osteoporosis drug and more. 

News
December 22, 2019
3 min read
Save

Alirocumab may reduce stroke risk without increasing odds of hemorrhage

Alirocumab may reduce stroke risk without increasing odds of hemorrhage

New data from the ODYSSEY Outcomes trial show that alirocumab is effective at reducing risk for any stroke without increasing risk for hemorrhagic stroke.

News
December 21, 2019
2 min read
Save

High-intensity statins confer reduced clinical, cerebral events in AF, stroke

High-intensity statins confer reduced clinical, cerebral events in AF, stroke

High-intensity statins may reduce adverse clinical and/or cerebral events in patients with acute ischemic stroke and atrial fibrillation, with particularly strong efficacy in patients who underwent revascularization and are younger than 75 years, according to findings published in the Journal of the American Heart Association.

News
December 13, 2019
4 min read
Save

FDA approves CV event risk reduction indication for icosapent ethyl

The FDA on Friday approved the use of icosapent ethyl as an adjunctive therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels, according to an agency press release.

News
December 13, 2019
3 min read
Save

CV event risk lower in women vs. men after non-ST segment elevation ACS

CV event risk lower in women vs. men after non-ST segment elevation ACS

Women who were enrolled in clinical trials had a lower risk for major adverse CV events compared with men after non-ST segment elevation ACS, according to a sex-specific analysis published in the Journal of the American College of Cardiology.

News
December 11, 2019
1 min read
Save

EVAPORATE

EVAPORATE

Plaque progression in patients assigned icosapent ethyl (Vascepa, Amarin) vs. placebo.

News
November 25, 2019
1 min read
Save

More mixed findings on omega-3, statins do not harm memory — top stories in cardiology

The top stories in cardiology last week included results from the VITAL trial presented at the American Heart Association Scientific Sessions that showed vitamin D and omega-3 did not reduce rates of first heart failure hospitalization, but researchers found that omega-3 supplementation could prevent recurrent heart failure hospitalizations.

News
November 20, 2019
2 min read
Save

Statins do not confer memory, cognition decline in older patients

Statins do not confer memory, cognition decline in older patients

Statin therapy in elderly patients was not linked to a greater decline in cognition or memory during a 6-year period, according to a study published in the Journal of the American College of Cardiology.

View more